<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01371266</url>
  </required_header>
  <id_info>
    <org_study_id>GFHNRC021</org_study_id>
    <nct_id>NCT01371266</nct_id>
  </id_info>
  <brief_title>Glycemic Effects of Honey</brief_title>
  <official_title>Glycemic Effects of Honey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>USDA Grand Forks Human Nutrition Research Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>USDA Grand Forks Human Nutrition Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Honey has been used as a sweetener for centuries. Recent data indicate that honey consumption
      may have beneficial effects upon glucose intolerance, a health issue currently affecting 57
      million Americans of every age and ethnicity. In order to evaluate the glycemic effect of
      honey, the investigators will carry out a human trial assessing biomarkers of blood glucose
      responses, insulin sensitivity, oxidative stress, and inflammatory markers. Our primary
      objective is to determine the glycemic effects of honey in comparison to sucrose and high
      fructose corn syrup (HFCS). The investigators hypothesize that honey will promote improved
      glucose tolerance and insulin sensitivity compared to both sucrose and high fructose corn
      syrup in normal glycemic and glucose intolerant adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Glucose intolerance and insulin resistance are associated with the development of the
      metabolic syndrome and chronic diseases, including, hyperlipidemia, hypertension, obesity,
      and type II diabetes. Current National Institutes of Health statistics estimate that 1 in 6
      Americans have insulin resistance (www.diabetes.niddk.nih.gov/dm/pubs/statistics). Insulin
      resistance in humans is associated with glucose intolerance, enhanced oxidative stress,
      inflammation and alterations in lipid profiles. Improvements in glucose tolerance are
      associated with improved insulin sensitivity resulting in improved inflammatory and oxidative
      status. Dietary modification to reduced day-long serum insulin concentration is postulated to
      decrease hepatic cholesterol production through inhibition of HMG CoA reductase, the rate
      limiting enzyme involved in cholesterol synthesis.

      Maintenance of normal blood glucose is dependent on the body's ability to modulate insulin
      secretion in response to the glucose load consumed. Although diet may be an important factor
      in glucose tolerance, the role of nutritive sweeteners has not been clearly defined. Much
      research has been performed on the effect of dietary sugars on chronic disease risk factors,
      including animal studies, and human studies ranging from epidemiologic to controlled feeding
      trials with most of this work focused on the monosaccharides: fructose and glucose or the
      disaccharide, sucrose.

      Little work has been done on the comparative effects of honey and other nutritive sweeteners
      in relation to glucose tolerance and insulin sensitivity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve glucose, response for OGTT. Glucose-120 min OGTT-AUC</measure>
    <time_frame>15 weeks</time_frame>
    <description>Evaluation of the effect of the treatment nutritive sweeteners on glucose tolerance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin- 120 min OGTT - AUC</measure>
    <time_frame>15 weeks</time_frame>
    <description>Evaluation of the effect of the treatment nutritive sweeteners on insulin sensitivity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides - 120 min OGTT - AUC</measure>
    <time_frame>15 weeks</time_frame>
    <description>Evaluation of the effect of the treatment nutritive sweeteners on fat metabolism.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Markers</measure>
    <time_frame>15 weeks</time_frame>
    <description>Effect of nutritive sweetener intake on systemic inflammation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative Stress Markers</measure>
    <time_frame>15 weeks</time_frame>
    <description>Effect of nutritive sweetener intake on systemic oxidative stress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Lipids</measure>
    <time_frame>15 weeks</time_frame>
    <description>Effect of nutritive sweetener intake on lipid metabolism.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Pre-diabetes</condition>
  <arm_group>
    <arm_group_label>Honey</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>60.7 grams daily orally times 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 grams daily orally times 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Fructose Corn Syrup</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>65.7 grams daily orally times 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Honey</intervention_name>
    <description>60.7 grams orally daily times 14 days</description>
    <arm_group_label>CHO</arm_group_label>
    <arm_group_label>High Fructose Corn Syrup</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Fructose Corn Syrup 55 (HFCS 55)</intervention_name>
    <description>65.7 gram daily orally times 14 days</description>
    <arm_group_label>Honey</arm_group_label>
    <arm_group_label>CHO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CHO (sugar)</intervention_name>
    <description>50 grams daily orally times 14 days</description>
    <arm_group_label>Honey</arm_group_label>
    <arm_group_label>High Fructose Corn Syrup</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men and women between 20-80 years of age.

          2. Normal Glucose Tolerance

               -  Fasting glucose between â‰¤105 mg/dl

               -  Normal body weight or overweight (BMI 18-29.9)

          3. Impaired Glucose Tolerance

               -  Fasting glucose between 106-125 mg/dl

               -  Overweight or obese (BMI 25 - 39.9)

          4. Willingness to comply with the demands of the experimental protocol

          5. Sedentary Lifestyle

        Exclusion Criteria:

          1. Known uncontrolled disease process

          2. Diabetes mellitus

          3. Use of medications that affect glucose metabolism

          4. History of an eating disorder

          5. Pregnancy or breast feeding

          6. Inability to give consent

          7. Unwillingness or inability to consume the supplemental sugars
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan K. Raatz, PhD., RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Agriculture Research Service, United States Department of Agriculture, Grand Forks Human Nutrition Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grand Forks Human Nutrition Research Center</name>
      <address>
        <city>Grand Forks</city>
        <state>North Dakota</state>
        <zip>58201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bantle JP, Raatz SK, Thomas W, Georgopoulos A. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr. 2000 Nov;72(5):1128-34.</citation>
    <PMID>11063439</PMID>
  </reference>
  <reference>
    <citation>Mathern JR, Raatz SK, Thomas W, Slavin JL. Effect of fenugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects. Phytother Res. 2009 Nov;23(11):1543-8. doi: 10.1002/ptr.2795.</citation>
    <PMID>19353539</PMID>
  </reference>
  <reference>
    <citation>Raatz SK, Torkelson CJ, Redmon JB, Reck KP, Kwong CA, Swanson JE, Liu C, Thomas W, Bantle JP. Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women. J Nutr. 2005 Oct;135(10):2387-91.</citation>
    <PMID>16177201</PMID>
  </reference>
  <reference>
    <citation>Shah M, Adams-Huet B, Bantle JP, Henry RR, Griver KA, Raatz SK, Brinkley LJ, Reaven GM, Garg A. Effect of a high-carbohydrate versus a high--cis-monounsaturated fat diet on blood pressure in patients with type 2 diabetes. Diabetes Care. 2005 Nov;28(11):2607-12.</citation>
    <PMID>16249527</PMID>
  </reference>
  <reference>
    <citation>Andreozzi F, Laratta E, Procopio C, Hribal ML, Sciacqua A, Perticone M, Miele C, Perticone F, Sesti G. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol. 2007 Mar;27(6):2372-83. Epub 2007 Jan 22.</citation>
    <PMID>17242212</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2011</study_first_submitted>
  <study_first_submitted_qc>June 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2011</study_first_posted>
  <last_update_submitted>August 12, 2015</last_update_submitted>
  <last_update_submitted_qc>August 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>USDA Grand Forks Human Nutrition Research Center</investigator_affiliation>
    <investigator_full_name>Susan Raatz</investigator_full_name>
    <investigator_title>PhD, RD, Research Nutritionist</investigator_title>
  </responsible_party>
  <keyword>Glucose intolerance</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Insulin</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>honey</keyword>
  <keyword>Inflammation</keyword>
  <keyword>oxidative stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

